Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Inspiremd Inc (NSPR)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE Arca]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 7,145
  • Shares Outstanding, K 37,604
  • Annual Sales, $ 2,760 K
  • Annual Income, $ -8,440 K
  • 36-Month Beta 1.84
  • Price/Sales 1.98
  • Price/Cash Flow N/A
  • Price/Book 0.54
  • Price/Earnings ttm 0.00
  • Earnings Per Share ttm -8.64
  • Most Recent Earnings N/A on N/A
  • Next Earnings Date 02/13/19
  • Annual Dividend & Yield 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sectors:

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.13 +46.15%
on 12/24/18
0.22 -15.18%
on 01/18/19
+0.05 (+35.71%)
since 12/21/18
3-Month
0.13 +46.15%
on 12/24/18
0.27 -29.63%
on 10/25/18
-0.05 (-20.83%)
since 10/22/18
52-Week
0.13 +46.15%
on 12/24/18
9.17 -97.93%
on 01/31/18
-6.81 (-97.29%)
since 01/22/18

Most Recent Stories

More News
InspireMD Announces Results from Initial Clinical Study of The CGuard(TM) Embolic Prevention System (EPS) with SmartFit(TM) Technology

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced details...

NSPR : 0.19 (unch)
InspireMD's CGuard(TM) Embolic Prevention System to be Prominently Featured in Live Case Transmissions at LINC, 22nd to the 25th January 2019, in Leipzig, Germany

InspireMD, Inc. (NYSE AMER:NSPR), a leader in embolic prevention systems (EPS) / thrombus management technologies and neurovascular devices, today announced that its CGuard(TM) Carotid Embolic Prevention...

NSPR : 0.19 (unch)
InspireMD Announces the Distribution of CGuard(TM) Embolic Prevention System in South Africa

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that its...

NSPR : 0.19 (unch)
InspireMD Announces Publication of Meta-Analysis Citing Benefits of Next Generation Mesh-Covered Carotid Stent Systems

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced the publication...

NSPR : 0.19 (unch)
InspireMD Announces Positive Long-Term Safety and Efficacy Data from Ongoing CGuard(TM) EPS Registries at the Recent 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced details...

NSPR : 0.19 (unch)
InspireMD Announces Regulatory and Reimbursement Approval of CGuard(TM) Embolic Prevention System in Australia

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that its...

NSPR : 0.19 (unch)
Report: Developing Opportunities within InspireMD, Lakeland Industries, ALJ Regional, Alphatec, Jerash Holdings (US), and DocuSign -- Future Expectations, Projections Moving into 2018

In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of InspireMD, Inc. (NYSE:NSPR),...

NSPR : 0.19 (unch)
ALJJ : 1.38 (-0.93%)
LAKE : 11.28 (-2.34%)
DOCU : 45.85 (-2.45%)
ATEC : 1.65 (-4.07%)
JRSH : 6.75 (-0.31%)
InspireMD Announces Upcoming Presentations at the 45th Annual Symposium on Vascular and Endovascular Issues, Techniques, Horizons (VEITHsymposium)

InspireMD, Inc. (NYSE American: NSPR), developer of the CGuard(TM) Embolic Prevention System (EPS) for the prevention of stroke caused by the treatment of carotid artery disease, today announced that the...

NSPR : 0.19 (unch)
InspireMD to Report Third Quarter 2018 Financial Results and Provide Business Update on Tuesday, November 6

Conference Call Scheduled for 8am Eastern Time

NSPR : 0.19 (unch)
InspireMD Announces Presentation of Preliminary Cumulative Three-Year CGuard(TM) EPS Safety and Efficacy Data at the Transcatheter Cardiovascular Therapeutics 2018 Conference

Preliminary Three-Year Data Continue to Show Unprecedented Safety, Efficacy and Durability of Stroke Prevention in Treating Carotid Artery Stenosis

NSPR : 0.19 (unch)

Barchart Technical Opinion

The Barchart Opinion rating is a Hold. Short term, the outlook is Bearish.

See More Share

Trade NSPR with:

Business Summary

InspireMD Inc. is a medical device company focusing on the development and commercialization of its proprietary stent system technology, MGuard(TM). The Company's initial products are marketed for use mainly in patients with acute coronary syndromes, notably acute myocardial infarction and saphenous...

See More

Key Turning Points

2nd Resistance Point 0.22
1st Resistance Point 0.21
Last Price 0.19
1st Support Level 0.18
2nd Support Level 0.16

See More

52-Week High 9.17
Fibonacci 61.8% 5.72
Fibonacci 50% 4.65
Fibonacci 38.2% 3.58
Last Price 0.19
52-Week Low 0.13

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar